Guest guest Posted September 9, 2010 Report Share Posted September 9, 2010 This is something that is quite disturbing..but we all know occurs. Message from a friend. PLoS Medicine, the leading non-commercial medical journal, just published a highly significant article that shows that Big Pharma companies actually ghostwrite many articles that promote their drugs...and pay big money to ghostwriters and to " thought leaders " medicine who pretend to be the authors. Will the media expose this fraud? _http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000335\ _ (http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000335) Summary Points * Some 1500 documents revealed in litigation provide unprecedented insights into how pharmaceutical companies promote drugs, including the use of vendors to produce ghostwritten manuscripts and place them into medical journals. * Dozens of ghostwritten reviews and commentaries published in medical journals and supplements were used to promote unproven benefits and downplay harms of menopausal hormone therapy (HT), and to cast raloxifene and other competing therapies in a negative light. * Specifically, the pharmaceutical company Wyeth used ghostwritten articles to mitigate the perceived risks of breast cancer associated with HT, to defend the unsupported cardiovascular “benefits†of HT, and to promote off-label, unproven uses of HT such as the prevention of dementia, Parkinson's disease, vision problems, and wrinkles. * Given the growing evidence that ghostwriting has been used to promote HT and other highly promoted drugs, the medical profession must take steps to ensure that prescribers renounce participation in ghostwriting, and to ensure that unscrupulous relationships between industry and academia are avoided rather than courted. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.